| 2021 | | Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer | 은정우 |
| 2016 | | Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis | 조성원 |
| 2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
| 2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
| 2013 | | Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. | 정재연, 조성원 |
| 2020 | | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | 김순선, 정재연 |
| 2014 | | Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma. | 김순선, 안선주, 우현구, 정재연, 조성원, 조효정 |
| 2014 | | Prognostic significance of catalase expression and its regulatory effects on hepatitis B virus X protein (HBx) in HBV-related advanced hepatocellular carcinomas. | 왕희정, 이영수, 정재연, 조혜성 |
| 2021 | | Prognostic value of alpha-fetoprotein in patients who achieve a complete response to transarterial chemoembolization for hepatocellular carcinoma | 김순선, 정재연, 조효정 |
| 2013 | | Radiofrequency ablation of metastatic liver masses: recurrence patterns and prognostic factors based on radiologic features. | 김재근, 김태희, 박미진, 이기명, 정재연 |
| 2023 | | Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection | 김순선 |
| 2015 | | Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. | 정재연, 조성원 |
| 2023 | | Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis | 김순선 |
| 2022 | | Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma | 김봉완, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
| 2021 | | Role of immune cells in patients with hepatitis b virus‐related hepatocellular carcinoma | 정재연, 조효정 |
| 2020 | | Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2019 | | Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial | 정재연 |
| 2014 | | Surgical outcomes for solid pseudopapillary neoplasm of the pancreas. | 김욱환, 김지훈, 김진홍, 백남현, 유병무, 황재철 |
| 1999 | | Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma. | 김영수, 박찬희, 왕희정, 이광재, 임현이, 조성원, 진윤미, 함기백 |
| 2020 | | Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2014 | 김순선, 노오규, 양민재, 임선교, 정재연, 조효정, 황재철 |
| 2021 | | Update on liver disease management during the pandemic of coronavirus disease 2019 (Covid-19): 2021 kasl guideline | 김순선 |
| 2017 | | Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic cancer | 김진홍, 양민재, 유병무, 이현우, 황재철 |
